Condition
Advanced Solid Malignancies clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Advanced Solid Malignancies clinical trials that are recruiting, at sites in 9 countries (most in United States (3), China (3), Spain (2)). By phase: Phase 1/2 (4), Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 9Countries
Newest Advanced Solid Malignancies clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BC2027 treatment for adults with advanced solid cancers | Phase 1 | Shanghai, Shanghai, China | Recruiting | Jan 26, 2026 |
| BMS-986523 alone and with other cancer medicines for advanced KRAS-altered solid tumors | Phase 1/2 | Baltimore, Maryland and 7 other locations | Recruiting | Oct 31, 2025 |
| Engineered mitochondrial vaccine for advanced solid tumors | Phase 1 | Chengdu, Sichuan | Recruiting | Apr 15, 2025 |
| Evaluating GIM-122 for advanced solid tumors | Phase 1/2 | Los Angeles, California and 10 other locations | Recruiting | Sep 7, 2023 |
| Testing AZD9574 for advanced solid tumors alone and with other cancer treatments | Phase 1/2 | La Jolla, California and 31 other locations | Recruiting | Jun 14, 2022 |
| Evaluating PRJ1-3024 for advanced solid tumors | Phase 1/2 | Zhengzhou, Henan and 4 other locations | Recruiting | Apr 7, 2022 |
All recruiting trials (6)
-
BC2027 treatment for adults with advanced solid cancers
This phase 1 study will try BC2027, an experimental injectable drug, in adults with advanced solid tumors who have no standard treatment options.
-
BMS-986523 alone and with other cancer medicines for advanced KRAS-altered solid tumors
This treatment tests whether BMS-986523, alone or combined with chemotherapy or immunotherapy, helps people with advanced KRAS-altered lung, colorectal, or pancreatic cancers.
-
Engineered mitochondrial vaccine for advanced solid tumors
This study is testing a new vaccine made to help boost the immune system against advanced solid tumors in patients who can't or don't want to use standard treatments.
-
Evaluating GIM-122 for advanced solid tumors
This study is testing a new treatment called GIM-122 for adults with advanced solid tumors to see how safe it is and how well it works.
-
Testing AZD9574 for advanced solid tumors alone and with other cancer treatments
This study is testing a new cancer drug called AZD9574, both on its own and with other treatments, to see how well it works and how safe it is for people with advanced solid tumors.
-
Evaluating PRJ1-3024 for advanced solid tumors
This study is testing a new oral treatment called PRJ1-3024 to see if it is safe and effective for people with advanced solid tumors.
Related topics
Quick answers
How many Advanced Solid Malignancies clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (3 trials), China (3 trials), Spain (2 trials), Canada (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 4, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.